‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

Ryan Cross

Senior Science Correspondent

On Tuesday, drug discoverer and biotech entrepreneur Alpha Lee told scientists at a chemistry meeting about a new molecule to combat the Zika virus. There …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Large vaccine makers stand by their investments despite US headwinds

China’s biotech market is staging a comeback that US biotech can only wish for

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

AstraZeneca CEO says Europe is 'falling behind' on R&D and manufacturing investments

FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approval

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

‘Peo­ple will die’: End of NIH grants guts work be­tween aca­d­e­mics and com­pa­nies to counter next pan­dem­ic

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Large vac­cine mak­ers stand by their in­vest­ments de­spite US head­winds

Chi­na’s biotech mar­ket is stag­ing a come­back that US biotech can on­ly wish for

With aims to be­come a 'gen­er­a­tional biotech,' Zealand Phar­ma hires Lil­ly vet­er­an as sci­ence chief

As­traZeneca CEO says Eu­rope is 'falling be­hind' on R&D and man­u­fac­tur­ing in­vest­ments

FDA asks No­vavax for post-mar­ket­ing da­ta of its Covid vac­cine, de­lay­ing ap­proval

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

Large vaccine makers stand by their investments despite US headwinds

China’s biotech market is staging a comeback that US biotech can only wish for

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

AstraZeneca CEO says Europe is 'falling behind' on R&D and manufacturing investments

FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approval

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence